Evidence concerning the role of Helicobacter pylori infection in the development of colorectal cancer remains controversial. The authors assessed the association of H. pylori seroprevalence with risk of colorectal cancer in a large population-based case-control study from Germany in [2003][2004][2005][2006][2007]. Serum antibodies to H. pylori in general and the cytotoxin-associated gene A protein (CagA) were measured in 1,712 incident colorectal cancer cases and 1,669 controls. The association between H. pylori seroprevalence and colorectal cancer risk was estimated by logistic regression, with adjustment for potential confounders and stratification by age group, sex, anatomic subsites, and cancer stage. Overall, H. pylori seroprevalence was higher in cases (46.1%) than in controls (40.1%), resulting in an age-and sex-adjusted odds ratio of 1.30 (95% confidence interval (CI): 1.14, 1.50). Adjustment for established colorectal cancer risk factors decreased the odds ratio to 1.26 (95% CI: 1.09, 1.47), with a further reduction to 1.18 (95% CI: 1.01, 1.38) after additional adjustment for previous colorectal endoscopy. Stratified analyses showed risk elevation to be essentially confined to left-sided colorectal cancer, with an odds ratio of 1.22 (95% CI: 1.02, 1.45), suggesting that H. pylori infection may be associated with a small yet relevant risk increase in the left colorectum. colorectal neoplasms; Helicobacter pylori; seroprevalence Abbreviations: CagA, cytotoxin-associated gene A protein; CI, confidence interval; ELISA, enzyme-linked immunosorbent assay; OR, odds ratio.
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Evidence concerning the role of Helicobacter pylori infection in the development of colorectal cancer remains controversial. The authors assessed the association of H. pylori seroprevalence with risk of colorectal cancer in a large population-based case-control study from Germany in [2003] [2004] [2005] [2006] [2007] . Serum antibodies to H. pylori in general and the cytotoxin-associated gene A protein (CagA) were measured in 1,712 incident colorectal cancer cases and 1,669 controls. The association between H. pylori seroprevalence and colorectal cancer risk was estimated by logistic regression, with adjustment for potential confounders and stratification by age group, sex, anatomic subsites, and cancer stage. Overall, H. pylori seroprevalence was higher in cases (46.1%) than in controls (40.1%), resulting in an age-and sex-adjusted odds ratio of 1.30 (95% confidence interval (CI): 1.14, 1.50). Adjustment for established colorectal cancer risk factors decreased the odds ratio to 1.26 (95% CI: 1.09, 1.47), with a further reduction to 1.18 (95% CI: 1.01, 1.38) after additional adjustment for previous colorectal endoscopy. Stratified analyses showed risk elevation to be essentially confined to left-sided colorectal cancer, with an odds ratio of 1.22 (95% CI: 1.02, 1.45), suggesting that H. pylori infection may be associated with a small yet relevant risk increase in the left colorectum. colorectal neoplasms; Helicobacter pylori; seroprevalence Abbreviations: CagA, cytotoxin-associated gene A protein; CI, confidence interval; ELISA, enzyme-linked immunosorbent assay; OR, odds ratio.
Colorectal cancer is the third most common cancer and the fourth leading cause of cancer-related death globally (1) . Its etiology is complex and remains incompletely understood, even though a number of genetic and environmental risk factors are meanwhile established (2, 3) . Several studies have suggested that chronic infection with the gastric bacterium Helicobacter pylori, which is an established strong risk factor for noncardia gastric cancer (4), may also be associated with a moderately increased risk of colorectal cancer (5) (6) (7) (8) . However, results were not consistent, and null results have also been reported (9) (10) (11) (12) (13) (14) (15) (16) (17) . Two pertinent metaanalyses combining results of 11 studies and 13 studies yielded summary odds ratios of 1.4 (95% confidence interval (CI): 1.1, 1.8) and 1.5 (95% CI: 1.2, 1.9) (18, 19) , respectively, suggesting a moderate yet relevant increase in colorectal cancer risk among those infected. However, evidence was limited by a number of factors, including limited sample size of studies and heterogeneous and often incomplete control of confounding. In particular, none of the previous studies controlled for former colorectal endoscopy, the strongest preventive factor known to date (20, 21) , and the number of cases remained below 385 in each of the single studies and below 1,710 in all studies combined, which limited the possibilities of more specific analyses according to cancer site, age, sex, or other key determinants of colorectal cancer risk. We thus aimed to assess the association between H. pylori seropositivity and the risk of colorectal cancer in a large population-based case-control study, paying particular attention to careful control for confounding, consideration of potential virulence factors of the infectious agent, and potential variation of risk with respect to age, sex, anatomic subsites, and cancer stage.
MATERIALS AND METHODS

Study population
Colorectal cancer cases and controls were drawn from the Darmkrebs: Chancen der Verhütung durch Screening (DACHS) Study, a population-based case-control study conducted in the Rhine-Neckar region in the southwest of Germany. Details of the study design have been reported elsewhere (21, 22) . Briefly, cases were patients aged !30 years, with a first histologically confirmed diagnosis of primary invasive colorectal cancer (International Classification of Diseases, Tenth Revision, codes C18-C20) between January 2003 and December 2007, and recruited during the first hospitalization due to cancer treatment or shortly afterward at their homes. Controls were randomly selected from lists of residents supplied by population registries and frequency matched to cases by 5-year age groups, sex, and county of residence. Additional inclusion criteria for both cases and controls were proficiency in the German language, the mental and physical ability to participate in a personal interview of about 1 hour, and no previous history of colorectal cancer. Written, informed consent was obtained from all participants. The study was approved by the ethics committees of the University of Heidelberg and the state medical boards of Baden-Württemberg and Rhineland-Palatinate, Germany.
Data collection
Personal interviews were conducted among eligible patients and controls by trained interviewers utilizing a standardized questionnaire to collect information on sociodemographic factors, anthropometric measures, medical history, family history of colorectal cancer, and lifestyle factors (such as smoking, alcohol consumption, nutrition, and physical activity). Furthermore, blood samples were obtained. For a minority of controls who were unwilling to give a full-length interview, a shorter self-administered questionnaire was utilized, and a blood sample was not requested. These subjects were not included in this analysis. On the basis of statistics on colorectal cancer patients treated in hospitals, the participating patients accounted for 50% of the expected number of eligible cases in the study Table continues region. The response rate among eligible control individuals was likewise slightly above 50%.
Laboratory analyses
Serum samples were stored at À80°C until laboratory analyses. Immunoglobulin G antibodies to H. pylori in general, as well as specific to the cytotoxin-associated gene A protein (CagA), a well-established virulence factor of H. pylori, were analyzed by enzyme-linked immunosorbent assays (ELISAs) (H. pylori ELISA (screen) and H. pylori p120 (CagA) ELISA; ravo Diagnostika, Freiburg, Germany). Classification of infection status was made according to the manufacturer's instructions, and borderline results were treated as negative. In sensitivity analyses, subjects with borderline results were excluded to explore the impact of and minimize potential misclassification of infection status. In additional sensitivity analyses, subjects who were H. pylori negative but CagA positive were reclassified as H. pylori positive, as this constellation may be indicative of past infection with H. pylori. All analyses were performed in a blinded fashion in the same laboratory. The sensitivity and specificity of the H. pylori ELISA were found to be 96% and 74%, respectively, when compared with results of the 13 C-urea breath test in a previous validation study (23) .
Statistical analysis
First, cases and controls were compared with respect to sociodemographic characteristics, lifestyle factors, family history, and personal medical history. Differences between cases and controls were assessed with Pearson's chi-square test. Then, multivariable unconditional logistic regression was used to estimate odds ratios and corresponding 95% confidence intervals for the association of H. pylori antibody status (overall and stratified by CagA status) with colorectal cancer risk. Odds ratios were adjusted for the matching factors age (years) and sex (control for county of residence did not have any relevant impact on odds ratio estimates and was therefore omitted), country of birth (Germany/other), educational level (8 categories based on years of schooling and qualifications attained (24): 1-3 ¼ low, 4-5 ¼ intermediate, 6-8 ¼ high), smoking status (former/current/never smoker), body mass index approximately 10 years prior to diagnosis (cases) or recruitment (controls) (kg/m 2 ), average lifetime alcohol consumption (grams of ethanol per day), average lifetime physical activity based on specific metabolic equivalent (MET) scores according to the Compendium of Physical Activities (25, 26) (MET-hours/week), history of colorectal cancer in first-degree relatives (yes/no), physician-diagnosed diabetes (yes/no), former colorectal endoscopy (yes/no), ever regular use (!2 times/week for !1 year) of nonsteroidal antiinflammatory drugs (NSAIDs: yes/no), and ever use of hormone replacement therapy among women (yes/no).
Additional stratum-specific analyses were carried out by age groups (<70 years, !70 years) and sex. Furthermore, risk of colorectal cancer was assessed by tumor location (colon vs. rectum, right sided vs. left sided) and stage (International Union Against Cancer (UICC) stage I/II vs. III/IV). Definitions of right colon and left colorectum included subsections from cecum to transverse colon and from splenic flexure to rectum, respectively.
All analyses were conducted by using SAS, version 9.2, statistical software (SAS Institute, Cary, North Carolina). Two-sided P < 0.05 was considered statistically significant.
RESULTS
Of the 1,945 cases and 2,399 controls recruited between January 2003 and December 2007, 508 controls who completed only a short questionnaire but did not give blood samples and 130 cases and 91 controls who participated in full-length interviews but also did not give blood samples were excluded. Another 24 cases and 17 controls were excluded because of unavailable H. pylori antibody status (for technical reasons unrelated to the characteristics of the study subjects), and 79 cases and 114 controls with a history of H. pylori eradication were excluded to avoid exposure misclassification. Finally, 1,712 cases and 1,669 controls were retained for analysis.
The distributions of sociodemographic, lifestyle, and medical characteristics of colorectal cancer cases and controls are presented in Table 1 . There were more males (59.3%) than females (40.7%). The mean ages of cases and controls were 68 (range: 33-94) and 69 (range: 34-98) years, respectively. Low education, smoking, obesity, diabetes, and family history of colorectal cancer were more common among cases than among controls, whereas regular use of nonsteroidal antiinflammatory drugs or hormone replacement therapy and a former colorectal endoscopy were more common among controls.
Overall, a higher seroprevalence of both H. pylori antibodies (46.1% vs. 40.1%; P < 0.0001 after controlling for age and sex) and CagA antibodies (34.0% vs. 29.9%; P ¼ 0.005 after controlling for age and sex) was observed among cases than among controls (Table 2) . Similar patterns were observed in sex-specific analyses among both men and women, with significant differences between cases and controls in each stratum except for CagA seroprevalence among women. Seroprevalence of H. pylori infection (for both H. pylori in general and CagA) increased with age among cases and controls (P trend < 0.0001 and P trend ¼ 0.002 for H. pylori in general among cases and controls, respectively; P trend < 0.0001 and P trend ¼ 0.005 for CagA, respectively, among cases and controls). This trend was also observed in both women and men. Table 3 shows the overall and age-specific associations between H. pylori infection and colorectal cancer risk derived from multivariable logistic regression. The overall age-and sex-adjusted odds ratio for colorectal cancer associated with H. pylori infection was 1.30 (95% CI: 1.14, 1.50). After control for established risk factors of colorectal cancer, the odds ratio decreased slightly to 1.26 (95% CI: 1.09, 1.47). Additionally including former colorectal endoscopy in the model resulted in a more substantial reduction of the odds ratio to 1.18 (95% CI: 1.01, 1.38), but a significant risk increase prevailed. The association of H. pylori infection with colorectal cancer risk was stronger in older (!70 years) than younger (<70 years) participants. Among those infected with H. pylori, the risk increase seemed more pronounced in the presence of CagA antibodies, but differences were small and confidence intervals of odds ratios were overlapping widely. Table 4 depicts results of sex-specific analyses. After adjustment for established colorectal cancer risk factors, a more pronounced association with H. pylori infection was seen among women than among men. However, sex-specific associations lost statistical significance after additional control for history of colorectal endoscopy.
As Table 5 shows, risk elevation was confined essentially to the left colorectum, and no increased risk was observed for the right colon after adjustment for potential confounders. In cancer stage-specific analyses, the association with H. pylori infection was found for early stage (stage I or II) but not for late stage (stage III or IV) colorectal cancer (Table 6 ). This pattern was most pronounced for CagA-positive infections.
In sensitivity analyses, after exclusion of subjects with borderline results of H. pylori serology (n ¼ 374, 10.5%), associations with colorectal cancer were stronger. Adjusted odds ratios for the association of H. pylori infection with overall and left-sided colorectal cancer risk were 1.27 (95% CI: 1.08, 1.51) and 1.32 (95% CI: 1.10, 1.59), respectively. Reclassification of subjects who were H. pylori negative and CagA positive (5% of cases and 6% of controls) yielded very similar results.
DISCUSSION
In this large case-control study, we found H. pylori infection to be more prevalent among patients with colorectal cancer than among controls. Although the association was attenuated by control for potential confounders, a moderate risk increase associated with the infection persisted in multivariate analyses. The risk increase was confined essentially to cancers in the left colorectum. The overall relative risk estimate of our study was in the same direction but slightly lower than summary estimates from previous meta-analyses. The latter had been based on much smaller studies, and asymmetry of funnel plots suggested possible publication bias even though statistical tests for publication bias were not significant given the limited number of studies included (18, 19) . Most previous studies were hospital-based case-control studies. The only 2 prospective studies had not found an association of H. pylori infection with colorectal cancer risk but had very limited power given the small numbers of cases (n ¼ 233 and n ¼ 118, respectively) (13, 14) . To our knowledge, this is by far the largest study that has assessed the association between H. pylori infection and colorectal cancer risk. The overall numbers of cases and controls were about 4-fold higher than in the largest study so far that had been based on a subsample of our current study recruited in 2003 and 2004 (7) . The total number of cases in our study (n ¼ 1,712) was also substantially higher than the sum of cases in all other previous studies (n ¼ 1,312). Furthermore, some of the previous studies did not control for potential confounding factors. To our knowledge, ours is the only study that controlled for previous colorectal endoscopy in addition to other established risk or preventive factors of colorectal cancer. Although our overall risk estimate without control for colorectal endoscopy (odds ratio (OR) ¼ 1.3) was only slightly lower than the summary odds ratios derived in previous meta-analyses (OR ¼ 1.4 and OR ¼ 1.5, respectively) (18, 19) , the difference became somewhat more pronounced after control for colorectal endoscopy. As the potential for publication bias is typically larger for smaller studies, these patterns suggest that the association of H. pylori infection with colorectal cancer may have been overestimated to some extent in previous work.
Only 2 previous studies have addressed the association of H. pylori infection with colorectal cancer risk according to subsite of the colorectum (14, 17) , but their power to detect possible site-specific variation in the association was limited due to small sample size. We distinguished cancers in the right colon and left colorectum, because there is increasing evidence for different etiology and biologic behavior of these cancers (27, 28) . We found the risk increase to be confined to the left colorectum. With an odds ratio of 1.29 in the fully adjusted model, the risk increase for left-sided cancers was strongest for CagA-positive infections. It has been suggested that the association between H. pylori infection and colorectal cancer risk may be due to excessive and prolonged release of gastrin among those who are infected (29) . Gastrin is a putative trophic factor for the colonic mucosa that may stimulate tumor growth (30) . Interestingly, animal models suggested the mitogenic action of gastrin to be limited to the left colon (31, 32) . Furthermore, a case-control study focusing on the relation between hypergastrinemia and colorectal adenoma found an increased risk only for distal colon adenoma (33) , and a prospective study found that elevated gastrin levels were more pronounced in their associations with rectal cancer than with colon cancer (13) . These findings are consistent with and may explain our findings of selective risk increase with respect to left-sided colorectal cancer.
In agreement with previous studies (34, 35), the seroprevalence of H. pylori increased with age in both cases and controls, whereas there were only small differences between sexes. The increase of prevalence with age most likely reflects a birth cohort effect, with lower infection rates during childhood among the younger cohorts, rather than new infections in middle and older adulthood (36) . Despite the decreasing prevalence in younger birth cohorts, almost half of our study population was still infected. This high proportion implies that the population attributable risk of H. pylori infection may still be substantial, despite the relatively modest risk increase. Assuming causality of the observed associations, we could attribute about 6.7% of all colorectal cancer and about 8.1% of left-sided colorectal cancer to H. pylori infection in our study. To our knowledge, this is the first study investigating the relation between H. pylori infection and colorectal cancer risk by cancer stage, and we found a positive association only for early stage colorectal cancer. As the proportions of left-sided cancers were similar among early (stage I þ II) and advanced (stage III þ IV) cancers, these differences cannot be attributed to differences in site distributions. A possible explanation for the risk difference between cancer stages might be that H. pylori may play a role as an initiator rather than as a promoter in the development of colorectal cancer. This suggestion is supported by evidence of a positive association between H. pylori infection and colorectal adenomas (6, 12, 37) . It is known that gastrin triggers proliferation of colonic mocusa through activation of gastrin-specific receptors (gastrin/cholecystokinin-B receptor (CCK B -R)) (29) . These specific receptors have been shown to be expressed early in the adenoma-carcinoma sequence (38) and also in advanced neoplasms (5) .
H. pylori strains that express the cagA gene have been identified to cause enhanced inflammatory response, elevated serum gastrin levels, and increased risk for gastric malignancies (39) . The few studies that have evaluated a potential role of this virulence factor in relation to colorectal cancer risk have remained inconclusive (5, 7, 14, 17, 40) . Shmuely et al. (40) reported H. pylori CagA-positive infection compared with H. pylori CagA-negative infection to be associated with a 10-fold risk for colorectal cancer in a study including 67 colorectal cancer patients. Although our more than 20-fold larger study also found a tentatively higher risk associated with CagA-positive than with CagA-negative infections, especially for cancer in the left colorectum, the difference was much smaller. Nevertheless, our results suggest that determination of CagA status, which was found to be highly relevant with respect to gastric cancer risk (39) , might also be useful for risk stratification with respect to colorectal cancer risk. Potential relevance of further virulence markers of the infectious agent, such as vacuolating toxin (VacA), Helicobacter cysteine-rich protein C (HcpC), and the chaperonin GroEL (41) , is yet to be determined.
Our study has specific strengths and limitations. Apart from the very large sample size and the population-based design, strengths include detailed ascertainment of potential confounding variables in in-depth personal interviews and additional validation of key covariates, such as previous colonoscopy, by medical records. Despite careful control for a large number of risk and preventive factors of colorectal cancer, we cannot exclude the potential of residual confounding by unmeasured covariates. In this context, the possibility has to be kept in mind that the association might be explained by another bacterial exposure correlated with H. pylori infection. Furthermore, factors related to socioeconomic status, particularly living conditions in childhood, which are closely linked to H. pylori infection (34), were measured by a limited set of variables including country of birth and educational level. Although other factors controlled for, such as smoking status, body mass index, alcohol consumption, physical activity, and former colorectal endoscopy, are all related to the factor of socioeconomic status to some extent, they mostly reflect living conditions during adulthood.
In addition, although the participation rates of 50% of all eligible cases in a large study region who had to be recruited in 22 hospitals and of 50% of eligible controls who had to agree to home visits are probably close to what is achievable in a population of this age (mean: 68-69 years and no upper age limit), we cannot rule out potential selection bias. Because of lack of reliable population-based cancer registration in the study area, lack of clinical registries in most of the collaborating clinics, and lack of representative data on key study variables from nonparticipating controls or the general population of the study area, direct assessment of potential selection bias was not possible. Incompleteness of case recruitment was due mainly to work overload of the physicians in charge of case notifications, which is unlikely to be related to the H. pylori infection status of patients. Better educated, more health conscious people who tend to have lower H. pylori prevalence might have been slightly overrepresented among participating controls. Although this may have led to some underestimation of H. pylori prevalence among eligible controls in descriptive analyses, careful adjustment for education and factors associated with health consciousness and health behavior (including, among other factors, smoking, body mass index, and previous colorectal endoscopy) should have prevented potential distortion of associations. Potential distortion by selective participation by age, nationality, and country of birth, which are known to be related to H. pylori infection, should likewise have been prevented by control for these factors in the multivariate analyses.
Moreover, serologic measurement of infection status is less than perfect. The degree of potential misclassification is difficult to quantify, because measurements considered as ''gold standard,'' such as gastroscopy-based measurements or the urea breath test, essentially reflect current exposure, whereas serology may remain positive for some time even after loss of the infection. The latter may not necessarily be a disadvantage, as past infection may even be more relevant for carcinogenesis. In any case, laboratory analyses conducted in a blinded manner using standardized procedures as performed in this study should ensure potential misclassification of the relevant exposure to be nondifferential with respect to disease. Such nondifferential misclassification might have led to potential underestimation rather than overestimation of a potentially true effect of the infection. Furthermore, most cases in our study were recruited during their hospital stay or a few days after surgery. Even though they might undergo treatment affecting H. pylori infection, such as antibiotic treatment during hospitalization, their antibody titers may not be altered substantially in such a short period, as studies have suggested that the minimal period for assessing H. pylori eradication by serology to be 6 months after therapy (42, 43) . Even if serologic results were artificially low because of potential treatment of cases, this would also have resulted in underestimation rather than overestimation of the effect. This suggestion is supported by the results of sensitivity analyses that suggested stronger association of H. pylori infection with colorectal cancer risk when potential misclassification of H. pylori infection is reduced by excluding subjects with borderline results in H. pylori serology. Furthermore, our study did not include measurements of potential mediators of H. pylori-related risk, such as gastrin levels (5, 13) and atrophic gastritis (9, 44) . Large prospective studies with additional measurements of such mediators would be desirable.
In summary, despite its limitations, our study suggests that there is a moderate yet relevant association between H. pylori infection and risk of colorectal cancer, especially for left-sided cancer and early stage cancers, which warrants confirmation and exploration of the underlying biologic mechanisms by future studies.
